EUVIMEDEUVIMED entdecken
Leserbrief

From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease

Shibing Hou, Weiqu Yuan iD

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70982 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Liver International, online erschienen am 13.11.2026. Verfasst von Shibing Hou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Med…. Die Arbeit nennt 4 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Acupuncture, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
  • The First Clinical Medical School of Guangdong Pharmaceutical University, Guangzhou, China.

ORCID-Profile: Weiqu Yuan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hou, S., & Yuan, W. (2026). From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease. Liver International, 46(12). https://doi.org/10.1111/liv.70982

Vancouver

Hou S, Yuan W. From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease. Liver International. 2026;46(12). doi:10.1111/liv.70982

BibTeX
@article{Hou2026,
  author = {Hou, Shibing and Yuan, Weiqu},
  title = {From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70982}
}
Kostenlos starten →